Workshops and Webinars
DMID hosts and participates in workshops and webinars to publicize recent developments, highlight successful strategies, and identify hurdles for infectious diseases product development. The focus of these workshops and webinars span many phases of product development, types of anti-infective products, and clinical indications.
Select examples of workshops related to product development
- Global Vaccine and Immunization Research Forum (GVIRF) webinars, 2021 to present (links to webinars on topics including mRNA vaccine technologies and vaccine adjuvants)
- Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants, October 25, 2024
- Developing Vaccines for Fungal Diseases: Coccidioidomycosis/Valley Fever, August 13-14, 2024
- Animal Models for Basic and Applied Studies of Respiratory Viruses Workshop, July 11-12, 2024
- Alternative Therapies to Penicillin for the Treatment of Syphilis, Feb. 13-14, 2024
- Systemic Approaches for ESKAPE Bacteria Antigen Discovery, Nov. 14-15, 2023
- Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation, Nov. 13-14, 2023
- CMV Vaccine Development – How Close Are We?, Sept 27-28, 2023
- Broadly Protective Coronavirus Vaccines: Supporting a Pathway Toward Clinical Development, Sept. 21-22, 2023
- The Role of BEI Resources in the Support of Arthropod Vector Research, April 21, 2023
- Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned from the COVID-19 Pandemic, March 1-3, 2023
- Enabling the evaluation of COVID-19 vaccines with correlates of protection, Feb. 16-17, 2023
- Continuing Development of Vaccines and Monoclonal Antibodies Against Zika Virus, Jan 31-Feb. 1, 2023
- Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) conference, Nov. 29-Dec. 1, 2022
- The Quest for Innovative Molecular Treatment Modalities for Intractable Diease Targets, Nov. 17-18, 2022
- Mucosal Vaccines for SARS-CoV-2: Scientific Gaps and Opportunities, Nov 7-8, 2022
- NIAID/FDA Bacteriophage Workshop, Aug 30-Sept 1, 2021
- Workshop on Pandemic Preparedness – The Prototype Pathogen Approach to Accelerate Medical Countermeasures, Nov 8, 2021
- NIAID/CDC Joint HSV Workshop, Nov. 3, 2022
- FDA, CDC, and NIH Co-sponsored Public Workshop Summary – Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea, April 23, 2021
- Driving Success in Vector Control Product Development for Public Health: The Critical Role of Preferred Product Characteristics and Target Product Profiles, June 26, July 2, August 6, 2020
- The COVID-19 Serology Studies Workshop, May 7, 2020
- Vector Control Product Development Pathway: Phase-Dependent Evidence Gathering, June 24-25, 2019
Additional Government Resources
- CDC-FDA Antimicrobial Resistant Isolates Bank – CDC has one of the largest collections of isolates gathered from national reference labs and tracking activities, taken from specimens in healthcare, food, and the community. Isolates are provided at no cost to approved institutions, and customers pay for shipping.
- Biomedical Advanced Research and Development Authority (BARDA) – Together with its industry partners, BARDA promotes the advanced development of medical countermeasures to protect Americans and respond to 21st century health security threats. BARDA funding announcements and instructions for meeting requests can be found on the BARDA website.
- National Center for Advancing Translational Sciences (NCATS) – NCATS staff are experts in many different fields relevant to translational research and science policy, from small molecules to human subjects protections. NCATS also offers a variety of tools and other resources for preclinical and clinical investigators.
- National Cancer Institute (NCI) – Resources for Researchers is a directory of NCI-supported tools and services for cancer researchers. Most resources are free of cost and available to anyone.
- National Institute of Biomedical Imaging and Bioengineering (NIBIB) – NIBIB supports a variety of product development efforts, including the Rapid Acceleration of Diagnostics (RADX) and Point-of-Care Technologies Research Network (POCTRN) programs to advance the development of diagnostics for infectious diseases.